Common clinical indications

• Prevention of Rh hemolytic disease of the newborn by administering to Rho(D)-negative mothers at risk of exposure to fetal Rho(D)-positive red blood cells (IM or IV products; see obstetric dosing guidelines).
• Prevention of Rho(D) isoimmunization in Rho(D)-negative individuals who have been transfused with Rho(D)-positive blood or cellular components (IM or IV products).
• Treatment of immune thrombocytopenic purpura (ITP) in nonsplenectomized Rho(D)-positive children, adolescents, and adults using IV formulations (WinRho-SDF, Rhophylac).

Frequently asked questions

What is Rho(D) Immune Globulin Intravenous (Human) used for?

Rho(D) Immune Globulin Intravenous (Human) (Rho(D) immune globulin (human)) is listed in YMed Atlas under Immune globulin. Indications, dosing, and safety information on this page summarize curated references—always confirm with current labeling, formularies, and local protocols.

How do I adjust dosing for renal impairment or special populations?